Skip to main content

Table 1 Demographic and clinical characteristics of European American Diabetes Heart Study (DHS) participants with complete data on vascular calcified plaque (n = 699)

From: Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study

 

Mean ± SD or %

Median (range)

Demographic information

Age (years)

62.8 ± 8.6

63.1 (40–86)

Gender (% female)

50.2%

 

Diabetes duration (years)

10.3 ± 7.1

8 (0–46)

% smoking (current or past)

59.9%

 

Self-reported history of prior CVD (%)

43.8%

 

Deceased (%)

22.3%

 

Deceased from CVD (%)

10.6%

 

Body composition

Height (cm)

168.7 ± 9.6

168.7 (122.8-195.4)

Weight (kg)

92.0 ± 19.6

89.5 (40.8-158.8)

BMI (kg/m2)

32.2 ± 6.2

31.3 (17.1-55.6)

Medications

Oral hypoglycemic agents

80.0%

 

Lipid lowering (%)

52.9%

 

Anti-hypertensive (%)

74.5%

 

Blood pressure (BP)

Systolic BP (mmHg)

139 ± 18

138 (94–214)

Diastolic BP (mmHg)

72 ± 10

72 (37–106)

Hypertension (%)

87.8%

 

Blood biochemistry

Glucose (mg/dL)

146.3 ± 53.7

135 (16–463)

Hemoglobin A1C (%)

7.4 ± 1.4

7.1 (4.6-16.6)

Hemoglobin A1C (mmol/mol)

57.0 ± 15.7

54.1 (26.8-157.9)

Total Cholesterol (mg/ dL)

183.6 ± 42.0

180 (65–391)

High density lipoprotein cholesterol (mg/dL)

42.7 ± 12.1

41 (8–98)

Low density lipoprotein cholesterol (mg/dL)

102.5 ± 32.2

100 (12–236)

Triglycerides (mg/dL)

198.6 ± 124.3

170 (30–1068)

Vascular imaging

Coronary artery calcified plaque

1893 ± 3515

420 (0–50415)

Carotid artery calcified plaque

346 ± 705

56 (0–5954)

Abdominal aortic calcified plaque

12113 ± 16353

4561 (0–94156)

Multi-bed score

1.95 ± 2.71

0.86 (0–23.57)